Cargando…
The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats
Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403076/ https://www.ncbi.nlm.nih.gov/pubmed/25901167 |
_version_ | 1782367313468588032 |
---|---|
author | Imenshahidi, Mohsen Razavi, Bibi Marjan Faal, Ayyoob Gholampoor, Ali Mousavi, Seyed Mehran Hosseinzadeh, Hossein |
author_facet | Imenshahidi, Mohsen Razavi, Bibi Marjan Faal, Ayyoob Gholampoor, Ali Mousavi, Seyed Mehran Hosseinzadeh, Hossein |
author_sort | Imenshahidi, Mohsen |
collection | PubMed |
description | Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated. Three doses of safranal (1, 2 and 4 mg/Kg/day) and spironolactone (50 mg/Kg/day) were administrated to the different groups of normotensive and hypertensive rats (at the end of 4 weeks treatment by DOCA-salt) for Five weeks. Then the effects of safranal on mean systolic blood pressure (MSBP) and heart rate (HR) were evaluated using tail cuff method. The duration of effect of safranal on SBP, was also evaluated. Our results indicated that chronic administration of safranal could reduce the MSBP in DOCA salt treated rats in a dose dependent manner. Safranal did not decrease the MSBP in normotensive rats. The data also showed that antihypertensive effects of safranal did not persist. In summary, our results showed that safranal exhibits antihypertensive and normalizing effect on BP in chronic administration. |
format | Online Article Text |
id | pubmed-4403076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-44030762015-04-21 The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats Imenshahidi, Mohsen Razavi, Bibi Marjan Faal, Ayyoob Gholampoor, Ali Mousavi, Seyed Mehran Hosseinzadeh, Hossein Iran J Pharm Res Original Article Safranal, the main component of Crocus sativus essential oil, exhibits different pharmacological activities. In this study, the effects of safranal, on blood pressure of normotensive and desoxycorticosterone acetate (DOCA) - salt induced hypertensive rats in chronic administration were investigated. Three doses of safranal (1, 2 and 4 mg/Kg/day) and spironolactone (50 mg/Kg/day) were administrated to the different groups of normotensive and hypertensive rats (at the end of 4 weeks treatment by DOCA-salt) for Five weeks. Then the effects of safranal on mean systolic blood pressure (MSBP) and heart rate (HR) were evaluated using tail cuff method. The duration of effect of safranal on SBP, was also evaluated. Our results indicated that chronic administration of safranal could reduce the MSBP in DOCA salt treated rats in a dose dependent manner. Safranal did not decrease the MSBP in normotensive rats. The data also showed that antihypertensive effects of safranal did not persist. In summary, our results showed that safranal exhibits antihypertensive and normalizing effect on BP in chronic administration. Shaheed Beheshti University of Medical Sciences 2015 /pmc/articles/PMC4403076/ /pubmed/25901167 Text en © 2015 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Imenshahidi, Mohsen Razavi, Bibi Marjan Faal, Ayyoob Gholampoor, Ali Mousavi, Seyed Mehran Hosseinzadeh, Hossein The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats |
title | The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats |
title_full | The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats |
title_fullStr | The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats |
title_full_unstemmed | The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats |
title_short | The Effect of Chronic Administration of Safranal on Systolic Blood Pressure in Rats |
title_sort | effect of chronic administration of safranal on systolic blood pressure in rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403076/ https://www.ncbi.nlm.nih.gov/pubmed/25901167 |
work_keys_str_mv | AT imenshahidimohsen theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT razavibibimarjan theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT faalayyoob theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT gholampoorali theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT mousaviseyedmehran theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT hosseinzadehhossein theeffectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT imenshahidimohsen effectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT razavibibimarjan effectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT faalayyoob effectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT gholampoorali effectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT mousaviseyedmehran effectofchronicadministrationofsafranalonsystolicbloodpressureinrats AT hosseinzadehhossein effectofchronicadministrationofsafranalonsystolicbloodpressureinrats |